| Logo | Name | Σ |
|---|---|---|
 | Shionogi & Co., Ltd Philosophy The purpose of the Shionogi Group's corporate activities is, as expressed in the opening of its Company Policy, to "supply the best possible medicine to protect the health and wellbeing of the patients we serve." This eternal and unwavering corporate philosophy is a statement of our vision and value to society. To achieve and live by the Company Policy, we have formulated Action Guidelines, which all Shionogi employees share and embrace as norms for daily activities. Through activities based on the Company Policy and the Action Guidelines, Shionogi will continue to contribute to patients, physicians and other healthcare providers, … Sectors: Pharmaceutical | 42 |
 | Bristol Myers Squibb At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, … Sectors: Pharmaceutical | 1737 |
 | IQVIA France Information, technology & amp; Services Iqvia, specialist in strategic consulting and analysis of health data (present in more than 100 countries and with 86,000 employees), supports its customers and partners to enable them to develop and market innovative therapies. In France since 1960, Iqvia France has been a key player in the health ecosystem at the interface of health and health establishments, pharmacies, government agencies, health authorities and payers. Its experts connect anonymized data, information, technologies and expertise to improve the care path of patients, from diagnosis to access and quality of care. Iqvia France thus recruits nearly 3000 patients … | 21 |
 | IncubAlliance Incubateur des start-up tech et deeptech du cluster Paris-Saclay Accompagnement de projets de création d'entreprises technologiques innovants Entrepreneurship, Consulting, Technology, Public R&D, Innovation, and Investment | 221 |
 | Fondation pour la Recherche sur la Biodiversité FRB - De la recherche à la société The Foundation for Research on Biodiversity is a platform for the different scientific players and stakeholders in society concerned with biodiversity. It was created in 2008, following the Grenelle Environment Forum, with the support of the ministries for research and ecology and eight public research establishments, joined by LVMH in 2014. Generating innovation, promoting scientific projects in association with society and developing studies, overviews and valuations are at the core of the foundation’s missions. Up until now, more than 170 structures, associations, businesses, managers or authorities have joined the FRB with the … | 59 |
 | Ipsen We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pauta exclusiva para México: Clave de Autorización COFEPRIS: 243300201B1962 CONSULTE A SU MÉDICO. Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, … Sectors: Pharmaceutical | 453 |
 | Groupe Hospitalier Diaconesses Croix Saint-Simon In the health service The Diaconesses Hospital Group Cross Saint-Simon is a hospital offering excellence in medicine, surgery and obstetrics without depending on the patient. Located east of Paris (close to the Place de la Nation), it supports 250,000 patients each year for preventive, diagnostic, curative and palliative acts. The establishment offers a large offer of care: internal medicine, orthopedic, digestive, gynecological and urological surgeries, proctology, oncology, rheumatology, acute geriatrics, emergencies, maternity and palliative care. It is also one of the most efficient fertility centers to date. Historically a pioneer in many areas and always turned to the future, the … Sectors: Health | 81 |
 | PULSALYS Incubate the startups Deeptech & amp; Accelerates the scientific innovations of the R & Amp; D Lyon-St Labos 🚀 Pulsalys, incubator and accelerator of Deep Tech innovations in Lyon & amp; St Etienne, builds products & amp; Innovative services of tomorrow, by transforming scientific discoveries from the University of Lyon laboratories into economic opportunities for businesses and startups. Created in December 2013 as part of the Investment Program for the Future (PIA) under the status of Acceleration Society for Technology Transfer (SATT), Pulsalys has become a key player in the attractiveness and economic development of the Lyon - St -Etienne … Tags: SATT Network Sectors: Research | 453 |
 | ADEME The Ecological Transition Agency! At ADEME - the ecological transition agency - we are resolutely engaged in the fight against global warming and the deterioration of resources. On all fronts, we mobilize citizens, economic actors and territories, give them the means to progress towards a society economical in resources, more sober in carbon, fairer and harmonious. In all areas - energy, circular economy, food, mobility, air quality, adaptation to climate change, soils ... - we advise, facilitate and help to finance many projects, from research to the sharing of solutions. At all levels, we put our expertise and prospective capacities … Sectors: National and local authorities | 7043 |
 | Future4care We unlock progress for tomorrow's healthcare Future4care is Europe’s leading ecosystem dedicated to digital health. Launched in 2021 through an alliance between Sanofi, Generali, Capgemini, and Orange, Future4care brings together key HealthTech players—major corporations, experts, healthcare professionals, public institutions, and startups—to foster meaningful synergies and drive innovation in healthcare. We believe that only a collective commitment from these multidisciplinary stakeholders will enable the emergence of European champions and accelerate the widespread adoption of AI- and digital-based solutions. That’s why we work every day to build unprecedented collaborations within our ecosystem, shaping the future of healthcare together. Join us! Sectors: Startup accelerator & VC | 257 |
 | SATT Sud-Est Transforming an invention into an innovation is a wonderful experience. And we’re fortunate, it is our job. From dream to reality, from lab to market | a researcher and his/her team make an extraordinary discovery. But how can an idea be transformed into a solution, and how can an invention be turned into an innovation? This is the start of a race against time to find the partner company capable of upholding that ambition. Fortunately, SATT Sud-Est is there to help in this undertaking and make this great story come true. Transforming an invention into an innovation is a wonderful … Tags: SATT Network Sectors: National and local authorities Research | 322 |
 | Institut du Cerveau – Paris Brain Institute Created in 2010, the Brain Institute is a scientific and medical research center of excellence dedicated to the study of the brain and the discovery of new treatments for nervous system diseases. Its innovative model brings together patients, doctors, researchers and entrepreneurs with a common objective: to transform fundamental discoveries into therapeutic solutions via a translational and interdisciplinary approach. Located in Paris in the heart of the Pitié-Salpêtrière hospital-the largest neurology pole in Europe-the Brain Institute brings together more than 900 international experts within 26 research teams, 11 advanced technological platforms, a clinical investigation center, a training organization, a Living … Sectors: Startup accelerator & VC | 322 |
 | Takeda Better Health, Brighter Future We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our … Sectors: Pharmaceutical | 1062 |
 | Amgen #WeareBiotech Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen … Sectors: Biotechnology | 1666 |
 | Alexion Pharmaceuticals, Inc. Transforming Lives, Every Day. Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex … Sectors: Biotechnology Pharmaceutical | 285 |
 | ANALGESIA 1st foundation of pain research in France A major public health problem, chronic pain today affects 1 out of 5 adults, or more than 12 million French people. And as the therapeutic arsenal is both aging and insufficient, almost 2 thirds of patients believe that their pain is insufficiently controlled. Pain also has a very important impact on occupational health. Dorsal pain is the 1st cause of incapacity in the world and musculoskeletal disorders represent the 1st cause of occupational disease in France. The pain in itself impacts 88 million working days per year in France. Fighting pain is therefore … Sectors: Research | 186 |
 | Gouvernement The official account of the French Government Follow Government news on this page in real time, including practical information, measures, numbers, results, and the profiles of economic players ! | 2847 |
 | Novo Nordisk Get updates around our progress and challenges to champion long-term health 💙 #DrivingChange Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments … Sectors: Pharmaceutical | 1532 |
 | Ministère de l'Agriculture et de la Souveraineté alimentaire The Ministry of Agriculture and Food Sovereignty is at the crossroads of all transitions - environmental, economic, health and societal. It is organized in three departments of central administration (food; teaching and research; economic and environmental performance of companies) whose action is coordinated by the general secretariat. In teaching and research, the ministry also has an essential role and offers training courses in the 4th grade to doctorate. Within his establishments distributed throughout France, he supports more than 216,000 young people in training in agriculture, forestry, animal health and nature. Due to the very great diversity of its missions, the … | 1215 |
 | Eurazeo Eurazeo is a leading global investment group Eurazeo is a leading global investment company, with a diversified portfolio of €34.1 billion in assets under management, including nearly €24.1 billion from third parties, invested in 590 companies. With its considerable private equity, private debt as well as real estate and infrastructure asset expertise, Eurazeo accompanies companies of all sizes, supporting their development through the commitment of its nearly 410 professionals and by offering deep sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free … Sectors: Finance | 1061 |
 | Bpifrance Bpifrance account, the public investment bank. Bpifrance, public investment bank, supports businesses, from priming to stock market quotes, from credit to equity. A privileged interlocutor, Bpifrance offers in each region financing or investment solutions adapted to each stage of business life. Bank partner of entrepreneurs, Bpifrance supports them sustainably to support their growth and competitiveness. The teams are at the heart of the regions, throughout the territory, through more than 50 regional locations. Financing of SMEs, business creation, international development, investment, creation/transmission, innovation, support, acceleration, and export guarantee Sectors: Bank | 13460 |
 | Sofinnova Partners Sofinnova Partners is a leading European VC firm in life sciences, specializing in healthcare and sustainability. Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential … | 435 |
 | Institut Curie Together, let's take speed cancer A recognized foundation of public utility, the Curie Institute associates one of the largest European research centers in cancerology and two cutting -edge hospitals. Founded in 1909 on a model designed by Marie Curie and still avant-garde, "from basic research to innovative care", the Institut Curie brings together 3,000 researchers, doctors, caregivers, technicians and administratives. Care The hospital ensemble of the Curie Institute is a reference center for breast cancers, eye tumors and pediatric cancers in particular. Research To advance the prevention, diagnosis and treatment of cancers, biologists, chemists, physicists, bio-informatians and doctors are mobilizing, … Sectors: Health | 1022 |
 | France Travail Official LinkedIn Page of France Work #wavecfrancetravail France Labor is a major player in the job market in France where he invests in facilitating the return to employment of job seekers and providing companies with their recruitment needs. The 55,000 employees in France work work on a daily basis to be the union between job seekers and businesses. France Work is a Key Player in the French Employment Market. Its Role is to help the unmployed find work and support companies to fulfil their recruitment requirements. Day-to-day, France Work's 55,000 Staff Provids that Vital Link Between Job Seekers and Companies. … Sectors: Human ressources | 6900 |
 | Pierre Fabre Laboratories New ways to care Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group : 💊 A pharmaceutical group with a strong positioning : medical and natural 🥈 The second largest dermo-cosmetics laboratory in the world 🥈 The second largest private French pharmaceutical group 🥇 The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including ; Pharmaceutical Care Pierre Fabre Oncologie Pierre Fabre Dermatologie Naturactive Eau Thermale … Sectors: Pharmaceutical | 847 |
 | EssilorLuxottica We are EssilorLuxottica, a global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. Formed in 2018 by the combination of Essilor and Luxottica, our Company combines two centuries of innovation and human endeavour to elevate vision care and the consumer experience around it. We are home to the most loved and widely-recognized vision care and eyewear brands in the world. Our proprietary eyewear brands include Ray-Ban, Oakley, Costa, Vogue Eyewear, Persol and Oliver Peoples, complemented by over 20 prestigious licensed brands. Our advanced lens technologies include Varilux, Crizal, Eyezen, Stellest and Transitions. We offer superior … Tags: CAC40 Sectors: Optical systems | 720 |
 | Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: Pharmaceutical | 3804 |
 | Banque Populaire Success is in you. ---------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------- | 1495 |
 | Veolia Veolia group aims to be the benchmark company for ecological transformation. With nearly 220,000 employees worldwide, the Group designs and provides game-changing solutions that are both useful and practical for water, waste and energy management. Through its three complementary business activities, Veolia helps to develop access to resources, preserve available resources, and replenish them. In 2021, the Veolia group supplied 79 million people with drinking water and 61 million people with wastewater service, produced nearly 48 million megawatt hours of energy and treated 48 million metric tons of waste. Veolia Environnement (listed on Paris Euronext: VIE) recorded consolidated revenue of … | 3219 |
 | AbbVie AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html. Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care Sectors: Pharmaceutical | 998 |
 | Gilead Sciences Creating Possible At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines Sectors: Biotechnology Pharmaceutical | 853 |
 | Karista Karista is a VC firm investing in game changers from scratch to success. Karista is an early-stage venture capital firm investing in ambitious entrepreneurs. For the past 20 years, we have been backing and guiding more than 100 companies from inception to success in Health, Digital, and Technology. Because we believe that investment is not only about money but mainly about people, we provide support to our founders and entrepreneurs very early-on. We come from different backgrounds and bring various skills to help nurturing our portfolio companies on many levels. We are currently deploying three European early stage funds: our … Sectors: Startup accelerator & VC | 237 |
 | MEDEF Act together for responsible growth. MEDEF is the first network of entrepreneurs in France. He defends and promotes businesses of all sizes and all sectors of activity. A privileged interlocutor of decision -makers and public authorities In all transparency, the MEDEF conducts a permanent lobbying action with all decision -makers at local, regional, national and European levels, in order to assert the company's point of view And to lighten your tax and regulatory burden: reform of professional tax, apprenticeship, business transmission, conventional rupture ... An essential partner of social dialogue Actual by law to negotiate on behalf of all companies … Sectors: NGO, Think Tank | 3043 |
 | GSK We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia Pharmaceutical products and Vaccines Sectors: Pharmaceutical | 1235 |
 | Novartis Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy Sectors: Pharmaceutical | 1906 |
 | MSD At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse … Sectors: Pharmaceutical | 2193 |
 | BioValley France Pôle de compétitivité santé du Grand Est Pôle de compétitivité Santé du Grand Est, BioValley France (ex Alsace BioValley) a pour mission de fédérer, développer et faire rayonner les acteurs de la filière à travers l’Innovation. Le Pôle s’appuie sur un réseau dynamique d’entreprises, une recherche académique et clinique de premier plan, ainsi qu’un réseau intégré de partenaires, acteurs-clés de l’innovation. BioValley France accompagne ses membres dans leur démarche d’Innovation R&D et leur permet d’accéder à des expertises à forte valeur ajoutée, dans une approche marché. BioValley France participe activement aux projets structurants et collaboratifs du territoire. Il contribue notamment … Sectors: Biotechnology French Cluster Public business cluster | 499 |
 | Medicen Paris Region Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and … Sectors: French Cluster Public business cluster | 747 |
 | Lyonbiopôle Auvergne-Rhône-Alpes The health innovation network As a French leading biocluster, Lyonbiopole Auvergne-Rhône-Alpes aims to federate the actors of innovation, to connect and promote them internationally and to support the emergence and development of innovative technologies, products and services to address global healthcare challenges. Lyonbiopole Auvergne-Rhône-Alpes gathers a community of more than 250 members among which world-class leaders, innovative small and medium size companies, research centers and university hospitals. At the center of this ecosystem, Lyonbiopole brings its members altogether to imagine the future of medicine and to develop breakthrough healthTech innovation available for tomorrow’s patients. Sectors: Biotechnology French Cluster Public business cluster | 521 |
 | Eurobiomed The service catalyst for the community of healthcare innovators in the south of France. Created in 2005, the Eurobiomed competitiveness cluster helps to unite and position the healthcare ecosystem of the Provence-Alpes-Côte-d'Azur and Occitanie/Pyrénées-Méditerranée regions at the cutting edge of innovation. Its aim is to foster the growth and projects of innovative healthcare companies in the region. From immunology and dermatology to neurology, oncology and digital health, Eurobiomed supports French and European public economic development strategies, helping to position its members as European champions and anchor France among the world leaders in healthcare innovation. Eurobiomed brings together all healthcare players, … Sectors: Biotechnology French Cluster Public business cluster | 506 |
 | Leem The professional organization of drug companies operating in France. Leem, medication companies, brings together companies in the pharmaceutical industry in France. Created over 130 years ago, the Leem now has nearly 270 adhering companies, which have almost 98 % of the total medication turnover in France. The pharmaceutical industry employs 100,000 people in more than 150 trades, and has recruited 10,000 employees per year for 10 years. Each year, the pharmaceutical industry invests 12 % of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in its R & AMP; D … Sectors: Startup accelerator & VC | 769 |
 | Greater Paris University Hospitals - AP-HP Nous soignons et innovons 365 jours par an. AP-HP (Greater Paris University Hospitals) is a European world-renowned university hospital. Its 39 hospitals treat 8 million people every year: in consultation, emergency, during scheduled or home hospitalizations. The AP-HP provides a public health service for everyone, 24 hours a day. This mission is a duty as well as a great source of pride. AP-HP is the leading employer in the Greater Paris area: 100.000 staff members – doctors, researchers, paramedical staff, administrative personnel and workers – work there. Toutes les spécialités médicales de la néonatologie à la gériatrie en passant par … Sectors: Health | 2331 |
 | Genopole Genopole, biocluster leader en France, Vivre l'innovation Created in 1998, Genopole® has a threefold mission: - develop a high-level research campus in genomics and post-genomics, focused on gene therapy in collaboration with the University Evry-Paris Saclay, - encourage the start-up and foster the development of biotech companies in the Paris region by providing personalized advice and support, including financial assistance - create a biopark in Evry-Courcouronnes in collaboration with the research campus. biocluster, research campus - academical laboratories, biotech companies, university, life sciences companies, Infrastructure - Shared-use technology platforms, and Biotherapy Sectors: Biotechnology | 362 |
 | France Biotech Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: … Sectors: Biotechnology Startup accelerator & VC | 982 |
 | Ipsos en France Ipsos is one of the main market research companies with more than 20,000 professionals operating in 90 markets. In a world that evolves quickly, relying on reliable data to make the right decisions has never been so important. At Ipsos, we are convinced that our customers are looking for more than a simple data supplier. They need a real partner who gives them precise and relevant information, and transforms them into knowledge to allow them to take action. This is why our experts, curious and passionate, deliver the most accurate measures to extract information that will have a real understanding … Sectors: Polling institute | 2631 |
 | Broca Living Lab Technological & psychosocial research to improve the health and social inclusion of senior citizens The Broca Living Lab, located within the Broca Hospital (AP-HP) in Paris (France), has been studying and contributing to the development and evaluation of new technologies that promote health, autonomy and social inclusion of older persons for more than 10 years. santé, living lab, innovation, maladie d'Alzheimer, études cliniques, robotique, qualité de vie, éthique, ergonomie cognitive, stimulation cognitive, dispositifs technologiques, autonomie, aidants, and gérontechnologies | 128 |
 | STATION F The biggest startup campus in the world. STATION F is the world's biggest startup campus based in Paris, gathering a whole entrepreneurial ecosystem under one roof. Startups Sectors: Startup accelerator & VC | 3677 |
 | Assurance Maladie Working for health insurance is to give a new dimension to your job and act on a daily basis for the protection of our health system. Take part in a wide variety of projects in a benevolent setting and be proud to contribute to an essential mission: to act together, to protect each. For almost 80 years, health insurance has played a major role in the service of national solidarity. We are convinced that the key to the sustainability of the health system is a collective responsibility and lies in the strong involvement of each of its actors. Within this … Sectors: Insurance | 1668 |
 | ANSM Agence nationale de sécurité du médicament et des produits de santé For safe, efficient, innovative and accessible health products The National Agency for the Safety of Medicines and Health Products is the public player who allows, on behalf of the State, access to health products in France and which ensures their safety throughout their life cycle. At the heart of the health system, we act at the service of patients and their safety. We promote access to innovative products via authorization procedures adapted to each stage of the life of the drug before and after its placing on the market. Through our assessments, expertise and our surveillance policy, we make sure … | 206 |
 | Haute Autorité de Santé Official page of the High Authority for Health (HAS), independent public authority of a scientific nature HAS is an independent public authority which aims to contribute to the regulation of the health system by quality. Its missions in the fields of the evaluation of health products, professional practices, organization of care and public health, aim to provide all patients and users with sustainable and equitable access to as effective, safe and efficient care as possible. | 604 |
 | Ministère de la Santé Official account of the ministry responsible for health and access to care. The Ministry of Health and Access to Care prepares and implements government policy in the fields of public health, prevention and access to care. health, solidarity, public administration, poverty, care, and solidarity | 1568 |
 | Groupe TF1 TF1, the French together In an environment marked by a rapid development of uses, the TF1 group occupies a leading position in the world of video by its ability to federate all audiences very much. Taking nearly 50 million viewers each week on its antennas and on average 33 million French and French each month in streaming, the group has an unrivaled gathering capacity. This is the strength of his industrial, editorial and cultural project: "TF1, the French together". Média leader in France, TF1 is present on the entire value chain with its activities as a content publisher, linear and … Sectors: Media | 5310 |
 | Microsoft Every company has a mission. What's ours? To empower every person and every organization to achieve more. We believe technology can and should be a force for good and that meaningful innovation contributes to a brighter world in the future and today. Our culture doesn’t just encourage curiosity; it embraces it. Each day we make progress together by showing up as our authentic selves. We show up with a learn-it-all mentality. We show up cheering on others, knowing their success doesn't diminish our own. We show up every day open to learning our own biases, changing our behavior, and inviting … Sectors: IT services | 11741 |
 | INRAE INRAE, National Institute for Research for Agriculture, Food and the Environment Inrae, the National Research Institute for Agriculture, Food and the Environment, is a major player in research and innovation created on January 1, 2020. A finalized research institute resulting from the merger between INRA and IRSTEA, INRAE brings together a community of 12,000 people, with just over 200 research units and around forty experimental units implanted in 18 centers. The Institute is positioned among the very first world leaders in agricultural and food sciences, in plants of plants and animals, and ranks 11th in ecology-environment. Inrae aims to be … Sectors: Research | 1811 |
 | GRDF GRDF, main gas distributor in France GRDF is the main operator of the natural gas distribution network in France. Our job is to design, build, exploit, maintain and develop this network. These infrastructure measures almost 200,000 km and are the longest network of natural gas in Europe: 5 times the turn of the Earth. This network, a key element of the energy transition, also meets the need for development of biomethane, vehicle natural gas and Power-to-Gas. Our 12,000 employees work in 9,500 municipalities to allow 11 million households and companies in France to benefit from access to our network. They … Sectors: Energy | 1922 |
 | Gustave Roussy Prevention / Care / Research / Teaching, serving patients with #Cancer. Gustave Roussy, the leading cancer control center in France and Europe, in the top 5 of cancer hospitals, constitutes a global center of expertise against cancer, at the service of patients. It brings together 3,100 professionals whose missions are prevention, care, research and education on two sites: in Villejuif and Chevilly-Larue (Grand Paris). A private establishment of collective interest, Gustave Roussy is authorized to receive donations and legacies. Cancerology, care, research, and teaching Sectors: Health | 552 |
 | PariSanté Campus Parisant Campus, here grows Digital health! Parisanté Campus aims to create a coherent and synergistic set of public and private operators, with the ambition of structuring a digital health and innovation sector of global influence. This set will be intended to settle on the site of the former Val-de-Grâce Army Instruction Hospital, and to create a network of Ile-de-France, national and international partnerships. The whole will be funded by unpublished investments from the recovery plan, and will be intended to be a major vector for creating medico -scientific, but also economic value. Based on a complete channel ranging from training … | 455 |
 | Pfizer We’re celebrating over 175 years of daring scientific innovation—and we’re not done yet. Let’s outdo yesterday. Protect your health at PfizerForAll.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines To apply science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe and effective and affordable medicines and health care services to the people who need them. Sectors: Pharmaceutical | 1530 |
 | AstraZeneca We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business Sectors: Pharmaceutical | 4000 |
 | Merck Group This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, … Tags: DAX30 Sectors: Biotechnology Pharmaceutical | 1570 |
 | PwC At PwC, we help clients drive their companies to the leading edge. We’re a tech-forward, people-empowered network with more than 370,000 people in 149 countries. Across audit and assurance, tax and legal, deals and consulting we help build, accelerate and sustain momentum. Find out more at www.pwc.com. PwC: Audit and assurance, consulting and tax services PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Content on this page has been prepared for general information only and is not intended to be relied upon as accounting, tax or … Sectors: Consulting, audit | 5920 |
 | Euronext Euronext is the leading European capital market infrastructure, covering the entire capital markets value chain, from listing, trading, clearing, settlement and custody, to solutions for issuers and investors. Euronext runs MTS, one of Europe’s leading electronic fixed income trading markets, and Nord Pool, the European power market. Euronext also provides clearing and settlement services through Euronext Clearing and its Euronext Securities CSDs in Denmark, Italy, Norway, and Portugal. As of December 2024, Euronext’s regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway, and Portugal host over 1,800 listed issuers with around €6 trillion in market capitalisation, a strong blue-chip … Sectors: Finance | 1090 |
 | Medtronic A global healthcare technology leader — boldly attacking the most challenging health problems facing humanity with innovations that transform lives. Sectors: Pharmaceutical | 1076 |
 | Biogen Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we … Sectors: Biotechnology | 728 |
 | Johnson & Johnson At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines Health Care, Medical Devices & Diagnostics, and Pharmaceuticals Sectors: Pharmaceutical | 4677 |
 | EY EY is building a better working world by creating new value for clients, people, society, the planet, while building trust in the capital markets. Enabled by data, AI and advanced technology, EY teams help clients shape the future with confidence and develop answers for the most pressing issues of today and tomorrow. EY teams in more than 150 countries work across a full spectrum of services in assurance, consulting, tax, strategy and transactions, strengthened by sector experience and diverse ecosystem partners. Find out more about the EY global network: http://ey.com/en_gl/legal-statement Advisory, Assurance, Tax, Transactions, Audit, Mergers, M&A, Financial Services, Accounting, … Sectors: Consulting, audit | 6197 |
 | Boehringer Ingelheim Our people are our strength. And, together with over 54,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward Privacy Notice: https://www.boehringer-ingelheim.com/privacy-notice Imprint: https://www.boehringer-ingelheim.com/imprint Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing Sectors: Animal Health Pharmaceutical | 2008 |
 | Eurostat High quality statistics and data on Europe. Lawful good. EUROSTAT is the statistical office of the European Union. Our mission is to provide high quality statistics and data on Europe. Our values: Show respect for our staff, partners and users Strive for excellence in everything we do Drive innovation in official statistics Promote service orientation Uphold professional independence ESS partnership Eurostat produces European statistics in partnership with National Statistical Institutes and other national authorities in the EU Member States. This partnership is known as the European Statistical System (ESS). It also includes the statistical authorities of the European Economic Area … Sectors: European Union | 11287 |